These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 30649381)

  • 1. Correlation Between Malaria-Specific Antibody Profiles and Responses to Artemisinin Combination Therapy for Treatment of Uncomplicated Malaria in Western Kenya.
    Odhiambo G; Bergmann-Leitner E; Maraka M; Wanjala CNL; Duncan E; Waitumbi J; Andagalu B; Jura WGZO; Dutta S; Angov E; Ogutu BR; Kamau E; Ochiel D
    J Infect Dis; 2019 May; 219(12):1969-1979. PubMed ID: 30649381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
    Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
    Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar.
    Tun KM; Jeeyapant A; Myint AH; Kyaw ZT; Dhorda M; Mukaka M; Cheah PY; Imwong M; Hlaing T; Kyaw TH; Ashley EA; Dondorp A; White NJ; Day NPJ; Smithuis F
    Malar J; 2018 Jul; 17(1):258. PubMed ID: 29996844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of complement immune response on artemisinin-based combination therapy in a population from malaria endemic region of Western Kenya.
    Wanjala CNL; Bergmann-Leitner E; Akala HM; Odhiambo G; Ogutu BR; Andagalu B; Kamau E; Ochiel D
    Malar J; 2020 Apr; 19(1):168. PubMed ID: 32349765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger.
    Grandesso F; Guindo O; Woi Messe L; Makarimi R; Traore A; Dama S; Laminou IM; Rigal J; de Smet M; Ouwe Missi Oukem-Boyer O; Doumbo OK; Djimdé A; Etard JF
    Malar J; 2018 Jan; 17(1):52. PubMed ID: 29370844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
    Grigg MJ; William T; Menon J; Dhanaraj P; Barber BE; Wilkes CS; von Seidlein L; Rajahram GS; Pasay C; McCarthy JS; Price RN; Anstey NM; Yeo TW
    Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
    Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
    Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
    Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO
    PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.
    Whegang Youdom S; Tahar R; Basco LK
    Malar J; 2017 Aug; 16(1):311. PubMed ID: 28774303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open randomized controlled trial to compare the efficacy of two fixed dose combinations of artemesinin based combinations for uncomplicated falciparum malaria in Bangladesh.
    Samad R; Rahman MR; Yunus EB; Hussain MA; Arif SM; Islam MN; Hafiz SA; Hossain MM; Faiz MA
    Bangladesh Med Res Counc Bull; 2013 Dec; 39(3):109-15. PubMed ID: 26118157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemether-lumefantrine for uncomplicated malaria: a systematic review.
    Omari AA; Gamble C; Garner P
    Trop Med Int Health; 2004 Feb; 9(2):192-9. PubMed ID: 15040555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria.
    Price RN; Nosten F; Luxemburger C; Kham A; Brockman A; Chongsuphajaisiddhi T; White NJ
    Trans R Soc Trop Med Hyg; 1995; 89(5):523-7. PubMed ID: 8560531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
    Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of malaria treatment outcome of generic and innovator's anti-malarial drugs containing artemether-lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children.
    Kilonzi M; Minzi O; Mutagonda R; Sasi P; Kamuhabwa A; Aklillu E
    Malar J; 2019 Apr; 18(1):133. PubMed ID: 30975147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemether-lumefantrine for treating uncomplicated falciparum malaria.
    Omari AA; Preston C; Garner P
    Cochrane Database Syst Rev; 2002; (3):CD003125. PubMed ID: 12137676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.